Lisa R Tannock

Lisa R Tannock, John David Fernandez, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Creation of an institutional semi-independent data monitoring committee

W. Stoops, Lisa R Tannock, M. Barton-Baxter, 2019, Clinical trials.

Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice

L. Cassis, S. Thatcher, Lisa R Tannock, 2019, Biology of Sex Differences.

Assessment of Gender-Affirming Hormone Therapy Requirements.

Lisa R Tannock, John David Fernandez, A. Villasante-Tezanos, 2019, LGBT health.

Adipocyte-Derived Serum Amyloid A Promotes Angiotensin II–Induced Abdominal Aortic Aneurysms in Obese C57BL/6J Mice

L. Cassis, P. Shridas, N. Webb, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases

P. Shridas, Lisa R Tannock, A. Patrick, 2021, Biomolecules.

Nutrition and inflammation: role of dietary cholesterol

A. Chait, S. Kahn, K. O’Brien, 2004 .

Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans

A. Chait, P. Little, P. Barrett, 2004, Diabetologia.

Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan.

A. Chait, P. Barrett, T. Wight, 2002, The Journal of clinical endocrinology and metabolism.

Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL.

A. Chait, P. Little, T. Wight, 2002, Journal of lipid research.

Proteoglycans Synthesized by Arterial Smooth Muscle Cells in the Presence of Transforming Growth Factor‐&bgr;1 Exhibit Increased Binding to LDLs

A. Chait, P. Little, T. Wight, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Serum amyloid A is not incorporated into HDL during HDL biogenesis[S]

N. Webb, D. Jennings, A. Ji, 2020, Journal of Lipid Research.

Durability of glycemic control using U-500 insulin.

Lisa R Tannock, Alexandria M Dailey, Jennifer A Gibert, 2012, Diabetes research and clinical practice.

Management of U-500 insulin users during inpatient admissions within a Veterans Affairs Medical Center.

Lisa R Tannock, Mary E Eberly, C. Palladino, 2016, Diabetes research and clinical practice.

Animal models of atherosclerosis: more than mice.

V. King, Lisa R Tannock, 2010, Atherosclerosis.

Management of Dyslipidemia in Endocrine Diseases.

Lisa R Tannock, 2022, Endocrinology and metabolism clinics of North America.

Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development11 This work was presented in part at the Arteriosclerosis, Thrombosis, and Vascular Biology annual conference, Denver, CO, 2006. Published, JLR Papers in Press, November 21, 2007.

J. Rutledge, H. Aung, Lisa R Tannock, 2008, Journal of Lipid Research.

Developing Faculty in Emerging Areas of Interdisciplinary Research.

A. Amin, M. Pignone, P. Finn, 2018, The American journal of medicine.

Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.

Lisa R Tannock, Joel C. Thompson, Patricia G. Wilson, 2018, Atherosclerosis.

Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.

M. Mayr, N. S. Gowert, M. Grandoch, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.

M. Mayr, N. S. Gowert, M. Grandoch, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Vascular proteoglycans and atherosclerosis: not over yet.

Lisa R Tannock, 2014, Atherosclerosis.

Increased atherosclerosis in mice with increased vascular biglycan content.

T. Tang, Lisa R Tannock, Joel C. Thompson, 2014, Atherosclerosis.

Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr−/− mice1[S]

C. Nelson, T. Tang, Lisa R Tannock, 2013, Journal of Lipid Research.

Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP

P. Little, Lisa R Tannock, Katherine D. Drennon, 2008, Archives of physiology and biochemistry.

Regulation of Vascular Proteoglycan Synthesis by Metabolic Factors Associated with Diabetes

Lisa R Tannock, Patricia G. Wilson, Katherine D. Drennon, 2007, Journal of Investigative Medicine.

U-500: a convenient insulin for a convenience food nation.

Lisa R Tannock, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition[S]

R. Charnigo, Lisa R Tannock, Joel C. Thompson, 2017, Journal of Lipid Research.

Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice1

L. Schaefer, Lisa R Tannock, Joel C. Thompson, 2010, Journal of Lipid Research.

Glucosamine supplementation accelerates early but not late atherosclerosis in LDL receptor-deficient mice.

A. Chait, V. King, R. Leboeuf, 2006, The Journal of nutrition.

Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein

A. Chait, P. Shridas, N. Webb, 2017, Journal of Lipid Research.

A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators.

T. Pawson, A. Bernstein, Y. Ben-David, 1991, The EMBO journal.

Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?

Lisa R Tannock, 2011, Atherosclerosis.

EXTREMELY LOW TESTOSTERONE DUE TO RELATIVE ENERGY DEFICIENCY IN SPORT: A CASE REPORT.

Lisa R Tannock, K. Kaiser, Ana Narla, 2019, AACE clinical case reports.

Risk Assessment and Guidelines for the Management of High Triglycerides

Lisa R Tannock, Anita A Bhat, 2015 .

Proteoglycans can mediate renal lipoprotein retention

Lisa R Tannock, 2006, Diabetologia.

The mineral factory: how to build a giant quartz reef

K. Regenauer‐Lieb, A. Berger, M. Herwegh, 2019, ASEG Extended Abstracts.

Role of serum amyloid A in atherosclerosis.

P. Shridas, Lisa R Tannock, 2019, Current opinion in lipidology.

A Murine Model of Obesity With Accelerated Atherosclerosis

V. King, F. D. de Beer, Lisa R Tannock, 2010, Obesity.

Serum Amyloid A Is an Exchangeable Apolipoprotein

P. McNamara, P. Shridas, N. Webb, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Serum amyloid A in atherosclerosis

V. King, Lisa R Tannock, Joel C. Thompson, 2011, Current opinion in lipidology.

Serum amyloid A3 is pro-atherogenic.

P. Shridas, N. Webb, F. D. de Beer, 2018, Atherosclerosis.

Thiol Oxidative Stress Induced by Metabolic Disorders Amplifies Macrophage Chemotactic Responses and Accelerates Atherogenesis and Kidney Injury in LDL Receptor–Deficient Mice

C. Phelix, R. LeBaron, Lisa R Tannock, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Proteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis

V. King, Lisa R Tannock, 2008, Reviews in Endocrine and Metabolic Disorders.

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

L. Goldstein, L. Braun, Clifford Chin, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.

J. Fischer, K. Williams, T. Tang, 2014, Journal of molecular and cellular cardiology.

Transforming growth factor‐β regulation of proteoglycan synthesis in vascular smooth muscle: Contribution to lipid binding and accelerated atherosclerosis in diabetes

P. Little, N. Osman, Micah L. Burch, 2010, Journal of diabetes.

Role of Dyslipidemia in Patients With Chronic Kidney Disease

Lisa R Tannock, A. Marino, 2013, Postgraduate medicine.

Circadian disruption with constant light exposure exacerbates atherosclerosis in male ApolipoproteinE-deficient mice

A. Daugherty, Deborah A. Howatt, J. S. Pendergast, 2020, Scientific Reports.

Managing Highly Insulin-Resistant Diabetes Mellitus: Weight Loss Approaches and Medical Management

Lisa R Tannock, Aparna Brown, D. Taneja, 2010, Postgraduate medicine.

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

A. Chait, K. Bornfeldt, M. V. von Herrath, 2004, The Journal of clinical investigation.

Dyslipidemia in patients with chronic kidney disease

Lisa R Tannock, Matthew R. Hager, A. Narla, 2017, Reviews in Endocrine and Metabolic Disorders.

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.

Jeffrey B. Boord, M. Blaha, M. Murad, 2020, The Journal of clinical endocrinology and metabolism.

New-onset diabetes after transplantation: focus on treatment strategies

Lisa R Tannock, A. Marino, A. Inankur, 2011 .

Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300252-JLR200

A. Chait, T. Wight, Lisa R Tannock, 2003, Journal of Lipid Research.

A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S]

N. Webb, Lisa R Tannock, Joel C. Thompson, 2015, Journal of Lipid Research.

Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms

T. Pawson, J. Bell, B. Howell, 1992, Molecular and cellular biology.

Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications

P. Shridas, N. Webb, F. D. de Beer, 2022, PloS one.

Hyperlipidemia: Where Is the Evidence for Combination Therapy?

Lisa R Tannock, 2015 .

Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice

A. Daugherty, D. Rateri, Deborah A. Howatt, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects

A. Chait, S. Kahn, M. Wener, 2005, Circulation.

Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

V. King, N. Webb, F. D. de Beer, 2008, The American journal of pathology.

Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein

P. Shridas, N. Webb, F. D. de Beer, 2023, Journal of lipid research.

Serum amyloid A is found on ApoB‐containing lipoproteins in obese humans with diabetes

V. King, Lisa R Tannock, Aparna Brown, 2013, Obesity.

SAA is Found on ApoB-Containing Lipoproteins in Obese Diabetic Humans

V. King, Lisa R Tannock, Aparna Brown, 2012, Obesity (Silver Spring, Md.).

Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes.

Lisa R Tannock, D. Karounos, L. Reynolds, 2007, Diabetes research and clinical practice.

Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

J. D. de Haan, J. Rutledge, P. Little, 2009, Journal of cellular and molecular medicine.

Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP.

P. Little, Lisa R Tannock, Katherine D. Drennon, 2008, Archives of Physiology and Biochemistry.

Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice

L. Cassis, S. Thatcher, Lisa R Tannock, 2019, Biology of Sex Differences.

Management of New-Onset Diabetes Mellitus After Transplantation

Lisa R Tannock, L. Reynolds, 2008, Postgraduate medicine.

The effects of a tectonic stress regime change on crustal-scale fluid flow at the Heyuan geothermal fault system, South China

K. Regenauer‐Lieb, A. Berger, M. Herwegh, 2020 .

Chronic environmental circadian disruption increases atherosclerosis and dyslipidemia in female, but not male, ApolipoproteinE-deficient mice

A. Daugherty, Deborah A. Howatt, Lisa R Tannock, 2023, Frontiers in Physiology.

Low Yield of Thyroid-Function Tests in Adult Hospitalized Patients — A Retrospective Analysis

R. Paudel, P. Dogra, Lisa R Tannock, 2020, International journal of general medicine.

Dyslipidemia in Chronic Kidney Disease

Lisa R Tannock, 2015 .

Extreme Insulin Resistance: Indications and Approaches to the Use of U-500 Insulin in Type 2 Diabetes Mellitus

Lisa R Tannock, Alexandria M Dailey, 2011, Current diabetes reports.

Clinical efficacy and patient satisfaction with U-500 insulin use.

Lisa R Tannock, D. Taneja, Alexandria M Dailey, 2010, Diabetes research and clinical practice.

A Case Report of Continuous Subcutaneous U-500 Insulin Administration in a Patient with Insulin Resistant Lipodystrophy

Lisa R Tannock, R. Kennedy, 2015 .

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Lisa R Tannock, Joel C. Thompson, Patricia G. Wilson, 2011, The American journal of pathology.

Transforming growth factor‐β regulation of proteoglycan synthesis in vascular smooth muscle: Contribution to lipid binding and accelerated atherosclerosis in diabetes

P. Little, N. Osman, Micah L. Burch, 2010, Journal of diabetes.

Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice Implications for Inflammation and Atherosclerosis

M. Grandoch, M. Elvers, P. Skroblin, 2016 .

METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS.